British Journal of Pharmacology,
Journal Year:
2024,
Volume and Issue:
181(18), P. 3303 - 3326
Published: May 15, 2024
Abstract
Background
and
Purpose
Amyotrophic
lateral
sclerosis
(ALS)
is
a
fatal
neurodegenerative
disorder
characterized
by
progressive
motor
neuron
(MN)
loss
consequent
muscle
atrophy,
for
which
no
effective
therapies
are
available.
Recent
findings
reveal
that
disease
progression
fuelled
early
aberrant
neuroinflammation
the
of
oligodendrocytes
with
neuroprotective
remyelinating
properties.
On
this
basis,
pharmacological
interventions
capable
restoring
pro‐regenerative
local
milieu
re‐establish
proper
oligodendrocyte
functions
may
be
beneficial.
Experimental
Approach
Here,
we
evaluated
in
vivo
therapeutic
effects
montelukast
(MTK),
an
antagonist
oligodendroglial
G
protein‐coupled
receptor
17
(GPR17)
cysteinyl‐leukotriene
1
(CysLT
R)
receptors
on
microglia
astrocytes,
SOD1
G93A
ALS
mouse
model.
We
chronically
treated
mice
MTK,
starting
from
symptomatic
stage.
Disease
was
assessed
behavioural
immunohistochemical
approaches.
Key
Results
Oral
MTK
treatment
significantly
extended
survival
probability,
delayed
body
weight
ameliorated
functionalityonly
female
mice.
Noteworthy,
restored
maturation
induced
significant
changes
reactive
phenotype
morphological
features
microglia/macrophages
astrocytes
spinal
cord
mice,
suggesting
enhanced
functions.
Importantly,
concomitant
MN
preservation
has
been
detected
after
administration.
No
beneficial
were
observed
male
highlighting
sex‐based
difference
protective
activity
MTK.
Conclusions
Implications
Our
results
provide
first
preclinical
evidence
indicating
repurposing
safe
marketed
anti‐asthmatic
drug,
promising
sex‐specific
strategy
personalized
treatment.
Developmental Neurobiology,
Journal Year:
2022,
Volume and Issue:
82(2), P. 160 - 174
Published: Jan. 26, 2022
Oligodendrocytes
(OLs)
are
a
major
type
of
glial
cells
in
the
central
nervous
system
that
generate
multiple
myelin
sheaths
to
wrap
axons.
Myelin
ensures
fast
and
efficient
propagation
action
potentials
along
axons
supports
neurons
with
nourishment.
The
decay
OLs
has
been
implicated
age-related
neurodegenerative
diseases
these
changes
generally
considered
as
an
inevitable
result
neuron
loss
axon
degeneration.
Noticeably,
undergo
dynamic
healthy
adult
brains,
is,
newly
formed
continuously
added
throughout
life
from
differentiation
oligodendrocyte
precursor
(OPCs)
pre-existing
may
degeneration
or
remodeling.
Increasing
evidence
shown
present
early
stages
diseases,
even
prior
significant
neuronal
functional
deficits.
More
importantly,
oligodendroglia-specific
manipulation,
by
either
deletion
disease
gene
enhancement
renewal,
can
alleviate
impairments
animal
models.
These
findings
underscore
possibility
not
passively
but
actively
involved
play
important
role
modulating
function
survival.
In
this
review,
we
summarize
recent
work
characterizing
both
brains
discuss
potential
targeting
oligodendroglial
treating
diseases.
Journal of Materials Chemistry B,
Journal Year:
2022,
Volume and Issue:
10(33), P. 6315 - 6327
Published: Jan. 1, 2022
Spontaneous
recovery
after
spinal
cord
injury
(SCI)
is
extremely
limited
since
the
severe
inflammatory
responses
lead
to
secondary
damage,
and
diseased
extracellular
matrix
(ECM)
fails
provide
inductive
cues
for
nerve
regeneration.
To
address
these
dilemmas,
herein,
we
propose
a
biomaterial-based
strategy
combining
neuroprotection
neuroinduction
SCI
repair.
Taking
advantage
of
microfluidic
chip,
constructed
imine-crosslinked
aldehyde-methacrylate-hyaluronan/collagen
hybrid
hydrogel
microfibers
incorporating
interleukin
4
(IL-4)-loaded
ZIF-8
nanoparticles
(IL4@ZIF-8
NPs).
The
possess
pivotal
traits
mimicking
natural
ECM
hold
neuroinductive
nanoalignment
viscoelasticity,
as
well
acidic
microenvironment-responsive
release
neuroprotective
IL-4.
Then,
elucidated
role
tailored
in
promoting
structural
functional
rats.
implanted
IL4@ZIF-8
NPs
protected
endogenous
neural
cells
by
M2
polarization
recruited
macrophages
suppressing
inflammation.
Additionally,
enhanced
neuronal
differentiation,
accelerated
axonal
regrowth,
synapse
formation
remyelination,
resulting
from
their
ECM-mimicking
oriented
nano-topography
viscoelasticity.
Moreover,
locomotor
function
was
also
improved
cues.
This
work
not
only
paves
steps
development
novel
class
multifunctional
hydrogels
that
manipulate
tissue
behavior
modifying
cellular
microenvironment
but
provides
intriguing
insights
repair
even
other
central
nervous
system
(CNS)
injuries
via
engineering
approaches.
Frontiers in Neurology,
Journal Year:
2023,
Volume and Issue:
14
Published: June 23, 2023
Multiple
sclerosis
and
the
major
sporadic
neurogenerative
disorders,
amyotrophic
lateral
sclerosis,
Parkinson
disease,
Alzheimer
disease
are
considered
to
have
both
genetic
environmental
components.
Advances
been
made
in
finding
predispositions
these
but
it
has
difficult
pin
down
agents
that
trigger
them.
Environmental
toxic
metals
implicated
neurological
since
human
exposure
is
common
from
anthropogenic
natural
sources,
damaging
properties
suspected
underlie
many
of
disorders.
Questions
remain,
however,
as
how
enter
nervous
system,
if
one
or
combinations
sufficient
precipitate
metal
results
different
patterns
neuronal
white
matter
loss.
The
hypothesis
presented
here
damage
selective
locus
ceruleus
neurons
causes
dysfunction
blood-brain
barrier.
This
allows
circulating
toxicants
astrocytes,
where
they
transferred
to,
damage,
oligodendrocytes,
neurons.
type
disorder
arises
depends
on
(i)
which
damaged,
(ii)
variants
give
rise
susceptibility
uptake,
cytotoxicity,
clearance,
(iii)
age,
frequency,
duration
toxicant
exposure,
(iv)
uptake
various
mixtures
metals.
Evidence
supporting
this
presented,
concentrating
studies
examined
distribution
system.
Clinicopathological
features
shared
between
disorders
listed
can
be
linked
Details
provided
applies
multiple
neurodegenerative
Further
avenues
explore
for
suggested.
In
conclusion,
may
play
a
part
several
While
further
evidence
support
needed,
protect
system
would
prudent
take
steps
reduce
pollution
industrial,
mining,
manufacturing
burning
fossil
fuels.
Molecular Neurodegeneration,
Journal Year:
2023,
Volume and Issue:
18(1)
Published: Oct. 19, 2023
Abstract
Amyotrophic
lateral
sclerosis
(ALS)
is
a
progressive
neurodegenerative
disorder
characterized
by
the
loss
of
both
upper
and
lower
motor
neurons,
resulting
in
muscle
weakness,
atrophy,
paralysis,
eventually
death.
Motor
cortical
hyperexcitability
common
phenomenon
observed
at
presymptomatic
stage
ALS.
Both
cell-autonomous
(the
intrinsic
properties
neurons)
non-cell-autonomous
mechanisms
(cells
other
than
are
believed
to
contribute
hyperexcitability.
Decoding
pathological
relevance
these
dynamic
changes
neurons
glial
cells
has
remained
major
challenge.
This
review
summarizes
evidence
from
clinical
preclinical
research,
as
well
underlying
mechanisms.
We
discuss
potential
role
cells,
particularly
microglia,
regulating
abnormal
neuronal
activity
during
disease
progression.
Identifying
early
such
system
may
provide
new
insights
for
earlier
diagnosis
ALS
reveal
novel
targets
halt
European Journal of Cell Biology,
Journal Year:
2021,
Volume and Issue:
100(7-8), P. 151179 - 151179
Published: Sept. 1, 2021
Cell
signal
transduction
pathways
are
essential
modulators
of
several
physiological
and
pathological
processes
in
the
brain.
During
overactivation,
these
signaling
may
lead
to
disease
progression.
Abnormal
protein
kinase
activation
is
associated
with
biological
dysfunctions
that
facilitate
neurodegeneration
under
different
conditions.
As
a
result,
understanding
brain
disorders'
development
or
Recent
research
findings
indicate
crucial
role
extracellular
signal-regulated
kinase-1/2
(ERK-1/2)
during
neuronal
process.
ERK-1/2
key
component
its
mitogen-activated
(MAPK)
group,
controlling
certain
neurological
activities
by
regulating
metabolic
pathways,
cell
proliferation,
differentiation,
apoptosis.
also
influences
elastic
properties,
nerve
growth,
cognitive
processing
injuries.
The
primary
goal
this
review
elucidate
ERK1/2
signaling,
which
involved
ALS-related
neuropathological
dysfunctions.
ALS
rare
disorder
category
mainly
affects
cells
responsible
for
voluntary
muscle
activity.
progressive,
means
symptoms
getting
worse
over
time,
there
no
cure
effective
treatment
avoid
reverse.
Genetic
abnormalities,
oligodendrocyte
degradation,
glial
immune
deregulation
Furthermore,
current
identifies
inhibitors
can
promote
neuroprotection
neurotrophic
effects
against
clinical-pathological
presentation
ALS.
future,
potential
could
be
used
related
neurocomplications.
Communications Biology,
Journal Year:
2022,
Volume and Issue:
5(1)
Published: Feb. 28, 2022
Amyotrophic
lateral
sclerosis
(ALS)
is
an
incurable
disease
characterized
by
proteinaceous
aggregate
accumulation
and
neuroinflammation
culminating
in
rapidly
progressive
lower
upper
motor
neuron
death.
To
interrogate
cell-intrinsic
inter-cell
type
perturbations
ALS,
single-nucleus
RNA
sequencing
was
performed
on
the
lumbar
spinal
cord
murine
ALS
model
SOD1G93A
transgenic
littermate
control
mice
at
peri-symptomatic
onset
stage
of
disease,
age
90
days.
This
work
uncovered
perturbed
tripartite
synapse
functions,
complement
activation
metabolic
stress
affected
cord;
processes
evidenced
cell
death
proteolytic
stress-associated
gene
sets.
Concomitantly,
these
pro-damage
events
co-existed
with
dysregulated
reparative
mechanisms.
provides
a
resource
cell-specific
niches
asserts
that
interwoven
dysfunctional
neuronal-glial
communications
mediating
neurodegeneration
are
underway
prior
to
overt
manifestation
recapitulated,
part,
human
post-mortem
cord.
Communications Biology,
Journal Year:
2022,
Volume and Issue:
5(1)
Published: Nov. 19, 2022
Myelin,
the
membrane
surrounding
neuronal
axons,
is
critical
for
central
nervous
system
(CNS)
function.
Injury
to
myelin-forming
oligodendrocytes
(OL)
in
chronic
neurological
diseases
(e.g.
multiple
sclerosis)
ranges
from
sublethal
lethal,
leading
OL
dysfunction
and
myelin
pathology,
consequent
deleterious
impacts
on
axonal
health
that
drive
clinical
impairments.
This
regulated
by
intrinsic
factors
such
as
heterogeneity
age,
extrinsic
cellular
molecular
interactions.
Here,
we
discuss
responses
of
OLs
injury,
perspectives
therapeutic
targeting.
We
put
forward
targeting
mature
disease
a
promising
strategy
support
CNS
Experimental and Therapeutic Medicine,
Journal Year:
2023,
Volume and Issue:
27(1)
Published: Nov. 21, 2023
Parkinson's
disease
(PD)
is
a
common
neurodegenerative
pathology
whose
major
clinical
symptoms
are
movement
disorders.
The
main
pathological
characteristics
of
PD
the
selective
death
dopaminergic
(DA)
neurons
in
pars
compacta
substantia
nigra
and
presence
Lewy
bodies
containing
α-synuclein
(α-Syn)
within
these
neurons.
associated
with
numerous
risk
factors,
including
environmental
genetic
mutations
aging.
In
many
cases,
complex
interplay
factors
leads
to
onset
PD.
mutated
α-Syn
gene,
which
expresses
pathologicalα-Syn
protein,
can
cause
Another
important
feature
neuroinflammation,
conducive
neuronal
death.
able
interact
certain
cell
types
brain,
through
phagocytosis
degradation
by
glial
cells,
activation
inflammatory
pathways
transmission
between
cells
neurons,
interactions
peripheral
immune
α-Syn.
addition
aforementioned
may
also
be
aging,
as
prevalence
increases
advancing
age.
aging
process
impairs
cellular
clearance
mechanism,
chronic
inflammation
accumulation
intracellular
α-Syn,
results
DA
present
review,
age-associated
pathogenicity
brain
discussed
facilitate
understanding
mechanisms
pathogenesis,
potentially
provide
insight
for
future
treatment